Microbiome Sequencing Services Market accounted for US$ 2056.34 million in 2020 and is estimated to be US$ 12331.2 million by 2030 and is anticipated to register a CAGR of 19.80%. The study of genetic material obtained directly from microbes is referred to as microbiome sequencing. Microbiome sequencing uses many approaches to collect human biodata in order to better understand sickness. It is the investigation of bacteria found in the human gut with the objective of better understanding human microbes and their function in health and disease. Previously, traditional microbiological procedures were employed to examine an individual's phenotype and genotype by obtaining samples from the skin, blood, or stool. Tools like next-generation testing are being utilised to generate human microbiome data as technology advances.
The report " Global Microbiome Sequencing Services Market, By Technology (Sequencing by Ligation (SBL), Sequencing by Synthesis (SBS), Short Gun Sequencing, Targeted Gene Sequencing, RNA Sequencing, and Other Technologies), By Application (Gastrointestinal Diseases, Infectious Diseases, CNS Diseases, Oncology, and Others), By End- User(Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, and Other End Users), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”
Key Highlights:
June 1, 2020 – Mérieux NutriSciences, a global leader in food safety and quality, has acquired Chestnut Labs, a provider of value-added food safety solutions, from Dairy Farmers of America.
3rd of February, 2020 – Mérieux NutriSciences, a global leader in food safety and a market leader in environmental testing in Italy, has announced the acquisition of C.P.G. Lab, an Italian company.
May 18th, 2021 Mérieux NutriSciences, a global leader in food safety, quality, and sustainability, announced that it has acquired majority control of UCGS in Wei Nan (Shaanxi Province).
23rd of October, 2020 – ProDigest, an intestinal research company, and Bio Fortis, a contract research organisation for Mérieux NutriSciences that specialises in nutrition, health, and microbiota studies, have signed a global partnership to strengthen and expand their international services. Their combined knowledge in gastrointestinal transit, bioavailability, metabolism, immune modulation, and efficacy of food compounds, functional ingredients, and medicines allows customers to produce medications, pre- and probiotics, and food ingredients more quickly and effectively.
Analyst View:
Surge in the genomic research and widening application area of the microbiome sequencing which is the boosting factor for the growth of the target market. The NIAID (National Institute of Allergy and Infectious Diseases) microbiome sequencing program involves the study and analysis of functional and structural specification, associated with concerned body sites and host organisms. However, the ethical and legal issues related to genome and microbiome sequencing which is the major restraining factor for the growth of the global market. Furthermore, the lack of skilled technicians for the next gene sequencing analysis which is another hampering factor for the growth of the global market.
Before purchasing this report, request a sample or make an inquiry by clicking the following link:
Key Market Insights from the report:
The Global Microbiome Sequencing Services Market accounted for US$ 2056.34 million in 2020 and is estimated to be US$ 12331.2 million by 2030 and is anticipated to register a CAGR of 19.80%. The global microbiome sequencing services market is segmented based on technology, application, end-user, and region.
By Technology, the Global Microbiome Sequencing Services Market is segmented into Sequencing by Ligation (SBL), Sequencing by Synthesis (SBS), Short Gun Sequencing, Targeted Gene Sequencing, RNA Sequencing, and Other Technologies.
By Application, the market is segmented in Gastrointestinal Diseases, Infectious Diseases, CNS Diseases, Oncology, and Others.
By End-User, the market is segmented in Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, and Other End Users.
By region, the Global Microbiome Sequencing Services Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in the Europe region accounts highest revenue share to the global microbiome sequencing services market due to the growing incidence of cancer. North America region is projected to register a high CAGR over the forecast period owing to the growing trend of the NGS which helps to recover cancer and the joint infections.
Competitive Landscape:
The key players operating the global surgical stapler market involves Baseclear BV, Clinical Microbiomics A/S, Merieux Nutrisciences, Jennewein Biotechnologie, Microbiome Insights Inc., Microbiome Therapeutics LLC, MR DNA, Second Genome, Ubiome Inc., and Zymo Research Corp.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
